Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AbMax Biotechnology
Beijing, Beijing, Chinaantibodychina.com ↗
- Ownership
- Private
- Employees
- ~36
- Development stage
- Commercial
01
Overview
AbMax Biotechnology specializes in rapid monoclonal and polyclonal antibody generation and custom reagent services. It has developed advanced platforms for vaccine antigen-specific antibodies and immunogenicity assays supporting non-clinical/clinical studies of vaccines and biologics. The company claims a high success rate (~90%) in monoclonal antibody projects with an average turnaround of just over six weeks. It serves both domestic Chinese and international clients in pharma/biotech.
- Therapeutic areas
- OtherImmunologyInfectious Diseases
- Modalities
- Monoclonal antibodyPolyclonal antibodyRecombinant proteinPeptides
- Industry
- Contract Research Organization
02
Partnerships
Collaborations with numerous domestic/international research institutions & enterprisesRecipient of Gates Foundation grant for global health work ($100K in Feb. 2020)
Beyond the preview
Go deeper on AbMax Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AbMax Biotechnology.